The Sumatriptan Pregnancy Registry was established by GlaxoSmithKline (GSK) in 2024 to monitor the safety of sumatriptan during pregnancy. It
may tell you to stop taking Mylan-Sumatriptan Tablets. The Use of Mylan-Sumatriptan Tablets During. Pregnancy: Do not use Mylan-Sumatriptan Tablets if you are.
SUMATRIPTAN (IMITREX/IMIGRAN concerning exposures to sumatriptan during pregnancy. A semi-annual
8.1 Pregnancy. Pregnancy Category C: There are no adequate and well-controlled trials of sumatriptan succinate injection in pregnant women. Sumatriptan.
Can taking sumatriptan in pregnancy cause miscarriage? Three small studies do not suggest taking sumatriptan in early pregnancy is linked to miscarriage.
pregnancy as well as during pregnancy and lactation. SUMMARY OF sumatriptan for secondary treatment of persistent headache in pregnancy.
Imitrex and pregnancy: The safety of Imitrex during pregnancy is unknown. Negative effects occurred in the fetuses of pregnant animals given sumatriptan during animal trials. (Sumatriptan is the
The pregnancy registry for sumatriptan was created in 2024 and includes 500 pregnancies prospectively enrolled through October 2024 (Sumatriptan and Naratriptan Pregnancy Registry, 2024). 23 TABLE 6 US Pregnancy Registries, Through
Through this Registry patients exposed to sumatriptan and naratriptan during pregnancy are identified, their pregnancies are followed, and
Comments
Great job 5 stars